Deltex Medical Group plc
DEMG.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | £2 | £2 | £2 | £2 |
| % Growth | -28.4% | 9.9% | -5.8% | – |
| Cost of Goods Sold | £1 | £1 | £1 | £1 |
| Gross Profit | £1 | £2 | £1 | £2 |
| % Margin | 63.3% | 70.4% | 65.6% | 64.5% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £1 | £2 | £2 | £1 |
| SG&A Expenses | £2 | £3 | £3 | £2 |
| Sales & Mktg Exp. | £1 | £1 | £1 | £1 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £2 | £3 | £3 | £3 |
| Operating Income | -£1 | -£1 | -£1 | -£1 |
| % Margin | -59.2% | -42.2% | -51.4% | -43.4% |
| Other Income/Exp. Net | -£0 | -£0 | -£0 | -£0 |
| Pre-Tax Income | -£1 | -£1 | -£1 | -£1 |
| Tax Expense | -£0 | -£0 | -£0 | -£0 |
| Net Income | -£1 | -£1 | -£1 | -£1 |
| % Margin | -72.2% | -46.3% | -42.8% | -33.3% |
| EPS | -0.001 | -0.002 | -0.002 | -0.002 |
| % Growth | 35.3% | 0% | -13.3% | – |
| EPS Diluted | -0.001 | -0.002 | -0.002 | -0.002 |
| Weighted Avg Shares Out | 1,181 | 685 | 581 | 526 |
| Weighted Avg Shares Out Dil | 1,181 | 685 | 581 | 526 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£1 | -£1 | -£1 | -£1 |
| % Margin | -56.4% | -33% | -33.1% | -22.1% |